林峻濠醫生 - 普通科
普通科
重點資料
- 醫務委員會註冊已驗證
- 專業資歷香港大學內外全科醫學士 · 2019 年醫科畢業
- 保險計劃資料整理中｜查看詳情
關於醫生
林峻濠醫生是香港註冊醫生。
學歷
- 香港大學內外全科醫學士2019
保險計劃
醫院轉介
可轉介入以下私家醫院
常見問題
林峻濠醫生好嗎？
林峻濠醫生是香港註冊醫生。資歷及註冊資料來自香港醫務委員會。ok.med 不評分，也不排名。
林峻濠醫生是做什麼的？
林峻濠醫生是普通科醫生。
研究及論文
共 10 篇
- UNICORN for Valve-in-Valve Transcatheter Aortic Valve Replacement: UNICORN Hong Kong Registry.JACC. Asia · 2026
- Percutaneous antegrade retrieval of an atrial septal occluder dislodged into the left ventricle.The Journal of invasive cardiology · 2026
- Safety and Efficacy of Concomitant Nirmatrelvir/Ritonavir and Direct Oral Anticoagulant Therapies for COVID-19 Among Patients With Atrial Fibrillation.Journal of the American Heart Association · 2026
- Cardiovascular safety of 5-fluorouracil and capecitabine in colorectal cancer patients: real-world evidence.Cardio-oncology (London, England) · 2025
- Atherosclerotic plaque, cardiovascular risk, and lipid-lowering strategies: a narrative review.Frontiers in cardiovascular medicine · 2025
- Transcatheter closure of right coronary cusp aneurysm-to-right ventricle paravalvular leak in a patient with complex congenital heart disease.The Journal of invasive cardiology · 2025
- Group G Streptococcus Infective Endocarditis Complicated by a Very Delayed Coronary Embolism.JACC. Case reports · 2025
- Aromatase Inhibitor Therapy Increases the Risk of New-Onset Atrial Fibrillation in Patients With Breast Cancer.JACC. Asia · 2024
- Editorial: Cardiovascular complications of emerging oncological therapies.Frontiers in cardiovascular medicine · 2024
- Immunopathogenesis of Immune Checkpoint Inhibitor Induced Myocarditis: Insights from Experimental Models and Treatment Implications.Biomedicines · 2023
論文資料來自 PubMed／Europe PMC，按姓名及機構自動配對；每項均可按連結核對。
僅供參考，不構成醫療建議。 閱讀完整免責聲明